Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikhail Popkov

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Immunological Methods|September 4, 2004
Isolation of human prostate cancer cell reactive antibodies using phage display technologyMikhail Popkov, Christoph Rader, Carlos F Barbas
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2005
Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivoNina Jendreyko, Mikhail Popkov, Christoph Rader, et al.
Journal of Molecular Biology|June 24, 2004
Promoter-targeted phage display selections with preassembled synthetic zinc finger libraries for endogenous gene regulationCaren V Lund, Pilar Blancafort, Mikhail Popkov, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2009
Instant immunity through chemically programmable vaccination and covalent self-assemblyMikhail Popkov, Beatriz Gonzalez, Subhash C Sinha, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 25, 2002
Integrin alpha(v)beta3 targeted therapy for Kaposi's sarcoma with an in vitro evolved antibodyChristoph Rader, Mikhail Popkov, John A Neves, et al.
Molecular and Cellular Biology|October 4, 2005
Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biologyCaren V Lund, Mikhail Popkov, Laurent Magnenat, et al.
The Journal of Biological Chemistry|November 13, 2004
Exploring strategies for the design of artificial transcription factors: targeting sites proximal to known regulatory regions for the induction of gamma-globin expression and the treatment of sickle cell diseaseTorbjörn Gräslund, Xuelin Li, Laurent Magnenat, et al.
Cancer Research|February 12, 2005
Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabodyMikhail Popkov, Nina Jendreyko, Dorian B McGavern, et al.
International Journal of Cancer|March 30, 2006
Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effectorMikhail Popkov, Christoph Rader, Beatriz Gonzalez, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2003
Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalystChristoph Rader, Subhash C Sinha, Mikhail Popkov, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Immunological Methods|September 4, 2004
Isolation of human prostate cancer cell reactive antibodies using phage display technologyMikhail Popkov, Christoph Rader, Carlos F Barbas
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2005
Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivoNina Jendreyko, Mikhail Popkov, Christoph Rader, et al.
Journal of Molecular Biology|June 24, 2004
Promoter-targeted phage display selections with preassembled synthetic zinc finger libraries for endogenous gene regulationCaren V Lund, Pilar Blancafort, Mikhail Popkov, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2009
Instant immunity through chemically programmable vaccination and covalent self-assemblyMikhail Popkov, Beatriz Gonzalez, Subhash C Sinha, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 25, 2002
Integrin alpha(v)beta3 targeted therapy for Kaposi's sarcoma with an in vitro evolved antibodyChristoph Rader, Mikhail Popkov, John A Neves, et al.
Molecular and Cellular Biology|October 4, 2005
Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biologyCaren V Lund, Mikhail Popkov, Laurent Magnenat, et al.
The Journal of Biological Chemistry|November 13, 2004
Exploring strategies for the design of artificial transcription factors: targeting sites proximal to known regulatory regions for the induction of gamma-globin expression and the treatment of sickle cell diseaseTorbjörn Gräslund, Xuelin Li, Laurent Magnenat, et al.
Cancer Research|February 12, 2005
Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabodyMikhail Popkov, Nina Jendreyko, Dorian B McGavern, et al.
International Journal of Cancer|March 30, 2006
Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effectorMikhail Popkov, Christoph Rader, Beatriz Gonzalez, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2003
Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalystChristoph Rader, Subhash C Sinha, Mikhail Popkov, et al.
Pageof 3